Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
UNLIMITED Watchlists, Portfolios, Screeners, and other Barchart tools with Barchart Premier. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Sangamo Therapeutics (SGMO)

Sangamo Therapeutics (SGMO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 139,547
  • Shares Outstanding, K 178,906
  • Annual Sales, $ 111,300 K
  • Annual Income, $ -192,280 K
  • 60-Month Beta 1.44
  • Price/Sales 0.79
  • Price/Cash Flow 21.18
  • Price/Book 1.67
Trade SGMO with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -0.91
  • Most Recent Earnings $-0.34 on 03/13/24
  • Latest Earnings Date N/A
  • Annual Dividend & Yield N/A (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Options Overview Details

View History
  • Implied Volatility 117.95% ( -84.14%)
  • Historical Volatility 198.05%
  • IV Percentile 44%
  • IV Rank 11.02%
  • IV High 1,058.08% on 11/14/23
  • IV Low 1.50% on 08/15/23
  • Put/Call Vol Ratio 0.29
  • Today's Volume 471
  • Volume Avg (30-Day) 687
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 9,513
  • Open Int (30-Day) 11,381

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 8 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/24
See More
  • Average Estimate -0.18
  • Number of Estimates 5
  • High Estimate -0.10
  • Low Estimate -0.27
  • Prior Year 0.12
  • Growth Rate Est. (year over year) -250.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.7600 +11.97%
on 03/18/24
1.3700 -37.88%
on 02/20/24
-0.5290 (-38.33%)
since 02/16/24
3-Month
0.3462 +145.81%
on 12/21/23
1.4800 -42.50%
on 02/16/24
+0.4688 (+122.66%)
since 12/18/23
52-Week
0.2911 +192.34%
on 11/13/23
2.0000 -57.45%
on 03/21/23
-1.1590 (-57.66%)
since 03/17/23

Most Recent Stories

More News
Sangamo: Q4 Earnings Snapshot

Sangamo: Q4 Earnings Snapshot

SGMO : 0.8510 (+9.10%)
Sangamo: Q3 Earnings Snapshot

Sangamo: Q3 Earnings Snapshot

SGMO : 0.8510 (+9.10%)
Sangamo: Q2 Earnings Snapshot

Sangamo: Q2 Earnings Snapshot

SGMO : 0.8510 (+9.10%)
Sangamo Therapeutics to Present Pre-clinical Data From Its Genomic Engineering Platform at the 26th Annual Meeting of the American Society of Gene & Cell Therapy (ASGCT)

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted 14 Sangamo abstracts for presentation at the...

SGMO : 0.8510 (+9.10%)
Sangamo Therapeutics Announces Strategic Update and Reports Preliminary First Quarter 2023 Financial Results

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicines company, today announced recent business highlights, including a strategic pipeline prioritization and restructuring, and reported certain...

SGMO : 0.8510 (+9.10%)
Strength Seen in Pharming Group N.V. Sponsored ADR (PHAR): Can Its 5.2% Jump Turn into More Strength?

Pharming Group N.V. Sponsored ADR (PHAR) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock suggests that there...

PHAR : 11.50 (+0.10%)
SGMO : 0.8510 (+9.10%)
Sangamo Therapeutics Announces First Quarter 2023 Conference Call and Webcast

Sangamo Therapeutics, Inc. (Nasdaq: SGMO), a genomic medicine company, announced today that the company is scheduled to release its first quarter 2023 financial results after the market closes on Wednesday,...

SGMO : 0.8510 (+9.10%)
Sangamo (SGMO) Loses -37.13% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

The heavy selling pressure might have exhausted for Sangamo (SGMO) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in...

SGMO : 0.8510 (+9.10%)
Sangamo (SGMO) Loses -24.09% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner

Sangamo (SGMO) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings...

SGMO : 0.8510 (+9.10%)
Sangamo Therapeutics (SGMO) Reports Q4 Loss, Tops Revenue Estimates

Sangamo (SGMO) delivered earnings and revenue surprises of 11.11% and 0.83%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?

SGMO : 0.8510 (+9.10%)
XENE : 42.89 (-2.43%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 56% Buy with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Sangamo Therapeutics, Inc. is a biotechnology company. It focuses on research and development of genomic therapies as well as develops medicines for patient with genetic diseases. The Company's product pipeline includes SB-525, SB-FIX, SB-318, SB-913, SB-728-T and SB-728-HSPC. Sangamo Therapeutics Inc.,...

See More

Key Turning Points

3rd Resistance Point 0.9977
2nd Resistance Point 0.9319
1st Resistance Point 0.8915
Last Price 0.8510
1st Support Level 0.7853
2nd Support Level 0.7195
3rd Support Level 0.6791

See More

52-Week High 2.0000
Fibonacci 61.8% 1.3472
Fibonacci 50% 1.1456
Fibonacci 38.2% 0.9439
Last Price 0.8510
52-Week Low 0.2911

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar